Cargando…
Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa
BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994263/ https://www.ncbi.nlm.nih.gov/pubmed/35395806 http://dx.doi.org/10.1186/s13287-022-02828-w |
_version_ | 1784684071347027968 |
---|---|
author | Brown, Christina Agosta, Patrina McKee, Christina Walker, Keegan Mazzella, Matteo Alamri, Ali Svinarich, David Chaudhry, G. Rasul |
author_facet | Brown, Christina Agosta, Patrina McKee, Christina Walker, Keegan Mazzella, Matteo Alamri, Ali Svinarich, David Chaudhry, G. Rasul |
author_sort | Brown, Christina |
collection | PubMed |
description | BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been investigated in preclinical and clinical studies, and the results have not been convincing. We applied a new approach in which primitive (p) MSC-derived retinal progenitor cells (RPCs) were examined to treat retinal degeneration in an rd12 mouse model of RP. METHODS: Well-characterized pMSCs and RPCs labeled with PKH26 were intravitreally injected into rd12 mice. The vision and retinal function of transplanted animals were analyzed using electroretinography. Animals were killed 4 and 8 weeks after cell transplantation for histological, immunological, molecular, and transcriptomic analyses of the retina. RESULTS: Transplanted RPCs significantly improved vision and retinal thickness as well as function in rd12 mice. pMSCs and RPCs homed to distinct retinal layers. pMSCs homed to the retinal pigment epithelium, and RPCs migrated to the neural layers of the retina, where they improved the thickness of the respective layers and expressed cell-specific markers. RPCs induced anti-inflammatory and neuroprotective responses as well as upregulated the expression of genes involved in neurogenesis. The transcriptomic analysis showed that RPCs promoted neurogenesis and functional recovery of the retina through inhibition of BMP and activation of JAK/STAT and MAPK signaling pathways. CONCLUSIONS: Our study demonstrated that RPCs countered inflammation, provided retinal protection, and promoted neurogenesis resulting in improved retinal structure and physiological function in rd12 mice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02828-w. |
format | Online Article Text |
id | pubmed-8994263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89942632022-04-10 Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa Brown, Christina Agosta, Patrina McKee, Christina Walker, Keegan Mazzella, Matteo Alamri, Ali Svinarich, David Chaudhry, G. Rasul Stem Cell Res Ther Research BACKGROUND: Currently, there is no treatment for retinal degenerative diseases (RDD) such as retinitis pigmentosa (RP). Stem cell-based therapies could provide promising opportunities to repair the damaged retina and restore vision. Thus far, primarily adult mesenchymal stem cells (MSCs) have been investigated in preclinical and clinical studies, and the results have not been convincing. We applied a new approach in which primitive (p) MSC-derived retinal progenitor cells (RPCs) were examined to treat retinal degeneration in an rd12 mouse model of RP. METHODS: Well-characterized pMSCs and RPCs labeled with PKH26 were intravitreally injected into rd12 mice. The vision and retinal function of transplanted animals were analyzed using electroretinography. Animals were killed 4 and 8 weeks after cell transplantation for histological, immunological, molecular, and transcriptomic analyses of the retina. RESULTS: Transplanted RPCs significantly improved vision and retinal thickness as well as function in rd12 mice. pMSCs and RPCs homed to distinct retinal layers. pMSCs homed to the retinal pigment epithelium, and RPCs migrated to the neural layers of the retina, where they improved the thickness of the respective layers and expressed cell-specific markers. RPCs induced anti-inflammatory and neuroprotective responses as well as upregulated the expression of genes involved in neurogenesis. The transcriptomic analysis showed that RPCs promoted neurogenesis and functional recovery of the retina through inhibition of BMP and activation of JAK/STAT and MAPK signaling pathways. CONCLUSIONS: Our study demonstrated that RPCs countered inflammation, provided retinal protection, and promoted neurogenesis resulting in improved retinal structure and physiological function in rd12 mice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02828-w. BioMed Central 2022-04-08 /pmc/articles/PMC8994263/ /pubmed/35395806 http://dx.doi.org/10.1186/s13287-022-02828-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Brown, Christina Agosta, Patrina McKee, Christina Walker, Keegan Mazzella, Matteo Alamri, Ali Svinarich, David Chaudhry, G. Rasul Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa |
title | Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa |
title_full | Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa |
title_fullStr | Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa |
title_full_unstemmed | Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa |
title_short | Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa |
title_sort | human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994263/ https://www.ncbi.nlm.nih.gov/pubmed/35395806 http://dx.doi.org/10.1186/s13287-022-02828-w |
work_keys_str_mv | AT brownchristina humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa AT agostapatrina humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa AT mckeechristina humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa AT walkerkeegan humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa AT mazzellamatteo humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa AT alamriali humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa AT svinarichdavid humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa AT chaudhrygrasul humanprimitivemesenchymalstemcellderivedretinalprogenitorcellsimprovedneuroprotectionneurogenesisandvisioninrd12mousemodelofretinitispigmentosa |